Clinical trial
Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
NCT00140023 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00140023 |
|---|---|
| Title | Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia |
| Official title | A Multi-center, Open Label Study to Evaluate the Efficacy and Safety of Azithromycin Microspheres in Subjects Identified as Having Low Risk Community Acquired Pneumonia (CAP) |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Community-Acquired Pneumonia |
| Intervention type | Drug |
| Interventions | Azithromycin microspheres 2.0 single dose |
| Enrollment | 47 |
| Start date | Sep 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Aug 31, 2005 |
| Last update posted | May 10, 2011 |
| Countries | Philippines |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: